Abo El Fetoh M, Helal G, Saleh I, Ewees M, Elshafey M, Elnagar M, et al. Cyclosporin A activates human hepatocellular carcinoma (HepG2 cells) proliferation: implication of EGFR-mediated ERK1/2 signaling pathway. Naunyn Schmiedebergs Arch Pharmacol. 2020;393:897-908 pubmed publisher

Bangaru S, Lang S, Schotsaert M, Vanderven H, Zhu X, Kose N, et al. A Site of Vulnerability on the Influenza Virus Hemagglutinin Head Domain Trimer Interface. Cell. 2019;177:1136-1152.e18 pubmed publisher

Williamson L, Flyak A, Kose N, Bombardi R, Branchizio A, Reddy S, et al. Early Human B Cell Response to Ebola Virus in Four U.S. Survivors of Infection. J Virol. 2019;93: pubmed publisher

Rosales Ramirez R, Ludert J. The Dengue Virus Nonstructural Protein 1 (NS1) Is Secreted from Mosquito Cells in Association with the Intracellular Cholesterol Transporter Chaperone Caveolin Complex. J Virol. 2019;93: pubmed publisher

Vunjak Novakovic G, Chen T. Human Tissue Engineered Model of Myocardial Ischemia-Reperfusion Injury. Tissue Eng Part A. 2018;: pubmed publisher

Ilmarinen T, Hiidenmaa H, Kööbi P, Nymark S, Sorkio A, Wang J, et al. Ultrathin Polyimide Membrane as Cell Carrier for Subretinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigment Epithelium. PLoS ONE. 2015;10:e0143669 pubmed publisher

Heo S, Thorpe S, Driscoll T, Duncan R, Lee D, Mauck R. Biophysical Regulation of Chromatin Architecture Instills a Mechanical Memory in Mesenchymal Stem Cells. Sci Rep. 2015;5:16895 pubmed publisher

Lam C, Zhao W, Liu G, Cai W, Gardner G, Adly G, et al. HAX-1 regulates cyclophilin-D levels and mitochondria permeability transition pore in the heart. Proc Natl Acad Sci U S A. 2015;112:E6466-75 pubmed publisher

Draganov D, Gopalakrishna Pillai S, Chen Y, Zuckerman N, Moeller S, Wang C, et al. Modulation of P2X4/P2X7/Pannexin-1 sensitivity to extracellular ATP via Ivermectin induces a non-apoptotic and inflammatory form of cancer cell death. Sci Rep. 2015;5:16222 pubmed publisher

Zhao Y, Yu L, Liu B, He X, Zhang B. Downregulation of P-gp, Ras and p-ERK1/2 contributes to the arsenic trioxide-induced reduction in drug resistance towards doxorubicin in gastric cancer cell lines. Mol Med Rep. 2015;12:7335-43 pubmed publisher

Zuo L, Pannell B, Re A, Best T, Wagner P. Po2 cycling protects diaphragm function during reoxygenation via ROS, Akt, ERK, and mitochondrial channels. Am J Physiol Cell Physiol. 2015;309:C759-66 pubmed publisher

Koyano Nakagawa N, Shi X, Rasmussen T, Das S, Walter C, Garry D. Feedback Mechanisms Regulate Ets Variant 2 (Etv2) Gene Expression and Hematoendothelial Lineages. J Biol Chem. 2015;290:28107-19 pubmed publisher

Bondarenko A, Parichatikanond W, Madreiter C, Rost R, Waldeck Weiermair M, Malli R, et al. UCP2 modulates single-channel properties of a MCU-dependent Ca(2+) inward current in mitochondria. Pflugers Arch. 2015;467:2509-18 pubmed publisher

Miller P, Bonn M, McKarns S. Transmembrane TNF-TNFR2 Impairs Th17 Differentiation by Promoting Il2 Expression. J Immunol. 2015;195:2633-47 pubmed publisher

Guasch A, Aranguren Ibáñez Ã, Pérez Luque R, Aparicio D, Martínez Høyer S, Mulero M, et al. Calcineurin Undergoes a Conformational Switch Evoked via Peptidyl-Prolyl Isomerization. PLoS ONE. 2015;10:e0134569 pubmed publisher

Ma B, Yu J, Xie C, Sun L, Lin S, Ding J, et al. Toll-Like Receptors Promote Mitochondrial Translocation of Nuclear Transcription Factor Nuclear Factor of Activated T-Cells in Prolonged Microglial Activation. J Neurosci. 2015;35:10799-814 pubmed publisher

Welzenbach K, Mancuso R, Krähenbühl S, Weitz Schmidt G. A novel multi-parameter assay to dissect the pharmacological effects of different modes of integrin αLβ2 inhibition in whole blood. Br J Pharmacol. 2015;172:4875-87 pubmed publisher

Jóhannsdóttir S, Jansook P, Stefánsson E, Loftsson T. Development of a cyclodextrin-based aqueous cyclosporin A eye drop formulations. Int J Pharm. 2015;493:86-95 pubmed publisher

Veroni C, Marnetto F, Granieri L, Bertolotto A, Ballerini C, Repice A, et al. Immune and Epstein-Barr virus gene expression in cerebrospinal fluid and peripheral blood mononuclear cells from patients with relapsing-remitting multiple sclerosis. J Neuroinflammation. 2015;12:132 pubmed publisher

Jang J, Huang Y, Zheng P, Jo M, Bertolet G, Zhu M, et al. Imaging of Cell-Cell Communication in a Vertical Orientation Reveals High-Resolution Structure of Immunological Synapse and Novel PD-1 Dynamics. J Immunol. 2015;195:1320-30 pubmed publisher

Lin P, Lin H, Kuo C, Yang L. N-terminal functional domain of Gasdermin A3 regulates mitochondrial homeostasis via mitochondrial targeting. J Biomed Sci. 2015;22:44 pubmed publisher

Wan J, Wang J, Liu T, Xie Z, Yu X, Li W. Surface chemistry but not aspect ratio mediates the biological toxicity of gold nanorods in vitro and in vivo. Sci Rep. 2015;5:11398 pubmed publisher

Wang X, Hu W, Zhang T, Mao Y, Liu N, Wang S. Irbesartan, an FDA approved drug for hypertension and diabetic nephropathy, is a potent inhibitor for hepatitis B virus entry by disturbing Na(+)-dependent taurocholate cotransporting polypeptide activity. Antiviral Res. 2015;120:140-6 pubmed publisher

Li P, Wang X, Zhao M, Song R, Zhao K. Polydatin protects hepatocytes against mitochondrial injury in acute severe hemorrhagic shock via SIRT1-SOD2 pathway. Expert Opin Ther Targets. 2015;19:997-1010 pubmed publisher

Yan R, Zhang Y, Cai D, Liu Y, Cuconati A, Guo H. Spinoculation Enhances HBV Infection in NTCP-Reconstituted Hepatocytes. PLoS ONE. 2015;10:e0129889 pubmed publisher

Worni Schudel I, Clark A, Chien T, Hwang K, Chen B, Foster M. Recovery of a human natural antibody against the noncollagenous-1 domain of type IV collagen using humanized models. J Transl Med. 2015;13:185 pubmed publisher

Yang H, Jung E, Ahn C, Lee G, Lee S, Kim S, et al. Elemol from Chamaecyparis obtusa ameliorates 2,4-dinitrochlorobenzene-induced atopic dermatitis. Int J Mol Med. 2015;36:463-72 pubmed publisher

Tyler A, Johansson A, Karlsson T, Gudey S, Brännström T, Grankvist K, et al. Targeting glucosylceramide synthase induction of cell surface globotriaosylceramide (Gb3) in acquired cisplatin-resistance of lung cancer and malignant pleural mesothelioma cells. Exp Cell Res. 2015;336:23-32 pubmed publisher

Li W, Fotinos A, Wu Q, Chen Y, Zhu Y, Baranov S, et al. N-acetyl-L-tryptophan delays disease onset and extends survival in an amyotrophic lateral sclerosis transgenic mouse model. Neurobiol Dis. 2015;80:93-103 pubmed publisher

Zhou Y, Zhao D, Yue R, Khan S, Shah S, Yin X, et al. Inflammasomes-dependent regulation of IL-1β secretion induced by the virulent Mycobacterium bovis Beijing strain in THP-1 macrophages. Antonie Van Leeuwenhoek. 2015;108:163-71 pubmed publisher

Wang J, Cao J, Dickson A, Poss K. Epicardial regeneration is guided by cardiac outflow tract and Hedgehog signalling. Nature. 2015;522:226-230 pubmed publisher

Vrzal R, Zenata O, Bachleda P, Dvorak Z. The effects of drugs with immunosuppressive or immunomodulatory activities on xenobiotics-metabolizing enzymes expression in primary human hepatocytes. Toxicol In Vitro. 2015;29:1088-99 pubmed publisher

Moguche A, Shafiani S, Clemons C, Larson R, Dinh C, Higdon L, et al. ICOS and Bcl6-dependent pathways maintain a CD4 T cell population with memory-like properties during tuberculosis. J Exp Med. 2015;212:715-28 pubmed publisher

Ramos Gómez M, Seiz E, Martínez Serrano A. Optimization of the magnetic labeling of human neural stem cells and MRI visualization in the hemiparkinsonian rat brain. J Nanobiotechnology. 2015;13:20 pubmed publisher

Esser Nobis K, Harak C, Schult P, Kusov Y, Lohmann V. Novel perspectives for hepatitis A virus therapy revealed by comparative analysis of hepatitis C virus and hepatitis A virus RNA replication. Hepatology. 2015;62:397-408 pubmed publisher

Dalzell A, Mistry P, Wright J, Williams F, Brown C. Characterization of multidrug transporter-mediated efflux of avermectins in human and mouse neuroblastoma cell lines. Toxicol Lett. 2015;235:189-98 pubmed publisher

He S, Lin B, Chu V, Hu Z, Hu X, Xiao J, et al. Repurposing of the antihistamine chlorcyclizine and related compounds for treatment of hepatitis C virus infection. Sci Transl Med. 2015;7:282ra49 pubmed publisher

Sharaf M, van den Heuvel M, Stevens D, Kamunde C. Zinc and calcium modulate mitochondrial redox state and morphofunctional integrity. Free Radic Biol Med. 2015;84:142-153 pubmed publisher

Chang E, Eckert M, Ali M, Riazifar H, Pone E, Liu L, et al. Facile supermolecular aptamer inhibitors of L-selectin. PLoS ONE. 2015;10:e0123034 pubmed publisher

Ochoa Alvarez J, Krishnan H, Pastorino J, Nevel E, Kephart D, Lee J, et al. Antibody and lectin target podoplanin to inhibit oral squamous carcinoma cell migration and viability by distinct mechanisms. Oncotarget. 2015;6:9045-60 pubmed

Bustos P, Perrone A, Milduberger N, Postan M, Bua J. Oxidative stress damage in the protozoan parasite Trypanosoma cruzi is inhibited by Cyclosporin A. Parasitology. 2015;142:1024-32 pubmed publisher

Chu X, Shih S, Shaw R, Hentze H, Chan G, Owens K, et al. Evaluation of cynomolgus monkeys for the identification of endogenous biomarkers for hepatic transporter inhibition and as a translatable model to predict pharmacokinetic interactions with statins in humans. Drug Metab Dispos. 2015;43:851-63 pubmed publisher

Zhang J, He S, Wang Y, Brulois K, Lan K, Jung J, et al. Herpesviral G protein-coupled receptors activate NFAT to induce tumor formation via inhibiting the SERCA calcium ATPase. PLoS Pathog. 2015;11:e1004768 pubmed publisher

Nie S, Yue H, Zhou J, Xing D. Mitochondrial-derived reactive oxygen species play a vital role in the salicylic acid signaling pathway in Arabidopsis thaliana. PLoS ONE. 2015;10:e0119853 pubmed publisher

Zeng Y, Liu X, Wu S, Zou C, Xie Q, Xu S, et al. Kaempferol Promotes Transplant Tolerance by Sustaining CD4+FoxP3+ Regulatory T Cells in the Presence of Calcineurin Inhibitor. Am J Transplant. 2015;15:1782-92 pubmed publisher

Ugajin T, Nishida K, Yamasaki S, Suzuki J, Mita M, Kubo M, et al. Zinc-binding metallothioneins are key modulators of IL-4 production by basophils. Mol Immunol. 2015;66:180-8 pubmed publisher

Lamikanra A, Merryweather Clarke A, Tipping A, Roberts D. Distinct mechanisms of inadequate erythropoiesis induced by tumor necrosis factor alpha or malarial pigment. PLoS ONE. 2015;10:e0119836 pubmed publisher

Seo K, Ki S, Shin S. Sestrin2-AMPK activation protects mitochondrial function against glucose deprivation-induced cytotoxicity. Cell Signal. 2015;27:1533-43 pubmed publisher

Grabowska M, Słuczanowska Głąbowska S, Kram A, Teresiński L, Piasecka M, Podhorska Okołów M, et al. The influence of immunosuppressants on the morphology, proliferating cell nuclear antigen (PCNA) and apoptosis in the rat ventral prostate. Histol Histopathol. 2015;30:1089-100 pubmed publisher

Sun X, Ou Z, Xie M, Kang R, Fan Y, Niu X, et al. HSPB1 as a novel regulator of ferroptotic cancer cell death. Oncogene. 2015;34:5617-25 pubmed publisher

Gautam M, Fujita D, Kimura K, Ichikawa H, Izawa A, Hirose M, et al. Transplantation of adipose tissue-derived stem cells improves cardiac contractile function and electrical stability in a rat myocardial infarction model. J Mol Cell Cardiol. 2015;81:139-49 pubmed publisher

Ciarcia R, Damiano S, Florio A, Spagnuolo M, Zacchia E, Squillacioti C, et al. The Protective Effect of Apocynin on Cyclosporine A-Induced Hypertension and Nephrotoxicity in Rats. J Cell Biochem. 2015;116:1848-56 pubmed publisher

Zhuang Y, Yasinta M, Hu C, Zhao M, Ding G, Bai M, et al. Mitochondrial dysfunction confers albumin-induced NLRP3 inflammasome activation and renal tubular injury. Am J Physiol Renal Physiol. 2015;308:F857-66 pubmed publisher

Yu T, Yang Y, Zhang J, He H, Ren X. Circumvention of cisplatin resistance in ovarian cancer by combination of cyclosporin A and low-intensity ultrasound. Eur J Pharm Biopharm. 2015;91:103-10 pubmed publisher

Venkatasubramanian S, Dhiman R, Paidipally P, Cheekatla S, Tripathi D, Welch E, et al. A rho GDP dissociation inhibitor produced by apoptotic T-cells inhibits growth of Mycobacterium tuberculosis. PLoS Pathog. 2015;11:e1004617 pubmed publisher

Kurahara L, Sumiyoshi M, Aoyagi K, Hiraishi K, Nakajima K, Nakagawa M, et al. Intestinal myofibroblast TRPC6 channel may contribute to stenotic fibrosis in Crohn's disease. Inflamm Bowel Dis. 2015;21:496-506 pubmed publisher

Youcef G, Belaidi E, Waeckel L, Fazal L, Clemessy M, Vincent M, et al. Tissue kallikrein is required for the cardioprotective effect of cyclosporin A in myocardial ischemia in the mouse. Biochem Pharmacol. 2015;94:22-9 pubmed publisher

van de Steeg E, Venhorst J, Jansen H, Nooijen I, DeGroot J, Wortelboer H, et al. Generation of Bayesian prediction models for OATP-mediated drug-drug interactions based on inhibition screen of OATP1B1, OATP1B1∗15 and OATP1B3. Eur J Pharm Sci. 2015;70:29-36 pubmed publisher

Clift D, Thorn R, Passarelli E, Kapoor M, LoPiccolo M, Richendrfer H, et al. Effects of embryonic cyclosporine exposures on brain development and behavior. Behav Brain Res. 2015;282:117-24 pubmed publisher

Watanabe T, Miyake M, Shimizu T, Kamezawa M, Masutomi N, Shimura T, et al. Utility of bilirubins and bile acids as endogenous biomarkers for the inhibition of hepatic transporters. Drug Metab Dispos. 2015;43:459-66 pubmed publisher

Benet M, Guzmán C, Pisonero Vaquero S, García Mediavilla M, Sánchez Campos S, Martínez Chantar M, et al. Repression of the nuclear receptor small heterodimer partner by steatotic drugs and in advanced nonalcoholic fatty liver disease. Mol Pharmacol. 2015;87:582-94 pubmed publisher

Clarke C, Robbins H, Tatalovich Z, Lynch C, Pawlish K, Finch J, et al. Risk of merkel cell carcinoma after solid organ transplantation. J Natl Cancer Inst. 2015;107: pubmed publisher

Pigeat R, Chausson P, Dreyfus F, Leresche N, Lambert R. Sleep slow wave-related homo and heterosynaptic LTD of intrathalamic GABAAergic synapses: involvement of T-type Ca2+ channels and metabotropic glutamate receptors. J Neurosci. 2015;35:64-73 pubmed publisher

Van den Hof W, Ruiz Aracama A, Van Summeren A, Jennen D, Gaj S, Coonen M, et al. Integrating multiple omics to unravel mechanisms of Cyclosporin A induced hepatotoxicity in vitro. Toxicol In Vitro. 2015;29:489-501 pubmed publisher

Hatano R, Ohnuma K, Otsuka H, Komiya E, Taki I, Iwata S, et al. CD26-mediated induction of EGR2 and IL-10 as potential regulatory mechanism for CD26 costimulatory pathway. J Immunol. 2015;194:960-72 pubmed publisher

Yano K, Mita S, Morimoto K, Haraguchi T, Arakawa H, Yoshida M, et al. Multiple Linear Regression Analysis Indicates Association of P-Glycoprotein Substrate or Inhibitor Character with Bitterness Intensity, Measured with a Sensor. J Pharm Sci. 2015;104:2789-94 pubmed publisher

Fan P, Song Y, Berezhkovskiy L, Cheong J, Plise E, Khojasteh S. Practical permeability-based hepatic clearance classification system (HepCCS) in drug discovery. Future Med Chem. 2014;6:1995-2012 pubmed publisher

Keane J, Tajouri L, Gray B. The effect of recombinant human growth hormone and insulin-like growth factor-1 on the mitochondrial function and viability of peripheral blood mononuclear cells in vitro. Appl Physiol Nutr Metab. 2015;40:105-15 pubmed publisher

Huang K, Kiefer C, Kamal A. Novel role for NFAT3 in ERK-mediated regulation of CXCR4. PLoS ONE. 2014;9:e115249 pubmed publisher

Batista M, Carneiro B, Braga A, Rahal P. Caffeine inhibits hepatitis C virus replication in vitro. Arch Virol. 2015;160:399-407 pubmed publisher

Godoy P, Lian J, Beech R, Prichard R. Haemonchus contortus P-glycoprotein-2: in situ localisation and characterisation of macrocyclic lactone transport. Int J Parasitol. 2015;45:85-93 pubmed publisher

Li M, Wang N, Gong H, Li W, Liao X, Yang X, et al. Ca²⁺ signal-induced cardiomyocyte hypertrophy through activation of myocardin. Gene. 2015;557:43-51 pubmed publisher

Müller J, Ossig C, Greiner J, Hauser S, Fauser M, Widera D, et al. Intrastriatal transplantation of adult human neural crest-derived stem cells improves functional outcome in parkinsonian rats. Stem Cells Transl Med. 2015;4:31-43 pubmed publisher

Lee M, Bingham K, Mitchell T, Meredith J, Rawlings J. Calcium mobilization is both required and sufficient for initiating chromatin decondensation during activation of peripheral T-cells. Mol Immunol. 2015;63:540-9 pubmed publisher

Qin W, Pan J, Wu Y, Bauman W, Cardozo C. Anabolic steroids activate calcineurin-NFAT signaling and thereby increase myotube size and reduce denervation atrophy. Mol Cell Endocrinol. 2015;399:336-45 pubmed publisher

Faralli J, Clark R, Filla M, Peters D. NFATc1 activity regulates the expression of myocilin induced by dexamethasone. Exp Eye Res. 2015;130:9-16 pubmed publisher

Nakamura H, Nakashima T, Hayashi M, Izawa N, Yasui T, Aburatani H, et al. Global epigenomic analysis indicates protocadherin-7 activates osteoclastogenesis by promoting cell-cell fusion. Biochem Biophys Res Commun. 2014;455:305-11 pubmed publisher

Li X, Zhu F, Jiang J, Sun C, Wang X, Shen M, et al. Synergistic antitumor activity of withaferin A combined with oxaliplatin triggers reactive oxygen species-mediated inactivation of the PI3K/AKT pathway in human pancreatic cancer cells. Cancer Lett. 2015;357:219-30 pubmed publisher

Biancofiore G, Bindi M, Miccoli M, Cerutti E, Lavezzo B, Pucci L, et al. Intravenous fenoldopam for early acute kidney injury after liver transplantation. J Anesth. 2015;29:426-432 pubmed publisher

Geyer M, Fairchild J, Moore D, Moore L, Henning P, Tham E. Recalcitrant hypocalcaemia in autoimmune enteropathy. Pediatrics. 2014;134:e1720-6 pubmed publisher

Hamilton B, Rybicki L, Dean R, Majhail N, Haddad H, Abounader D, et al. Cyclosporine in combination with mycophenolate mofetil versus methotrexate for graft versus host disease prevention in myeloablative HLA-identical sibling donor allogeneic hematopoietic cell transplantation. Am J Hematol. 2015;90:144-8 pubmed publisher

Cusack C, Nijhawan R, Miller B, Henien M, Malat G, Doyle A, et al. Vismodegib for locally advanced basal cell carcinoma in a heart transplant patient. JAMA Dermatol. 2015;151:70-2 pubmed publisher

Chen J, Xu Z, Wang F. Association between DNA methylation and multidrug resistance in human glioma SHG-44 cells. Mol Med Rep. 2015;11:43-52 pubmed publisher

Alavian K, Dworetzky S, Bonanni L, Zhang P, Sacchetti S, Li H, et al. The mitochondrial complex V-associated large-conductance inner membrane current is regulated by cyclosporine and dexpramipexole. Mol Pharmacol. 2015;87:1-8 pubmed publisher

Akbulut S, Elbe H, Eris C, Dogan Z, Toprak G, Yalcin E, et al. Effects of antioxidant agents against cyclosporine-induced hepatotoxicity. J Surg Res. 2015;193:658-66 pubmed publisher

Schaap M, Wackers P, Zwart E, Huijskens I, Jonker M, Hendriks G, et al. A novel toxicogenomics-based approach to categorize (non-)genotoxic carcinogens. Arch Toxicol. 2015;89:2413-27 pubmed publisher

Umsumarng S, Pitchakarn P, Sastraruji K, Yodkeeree S, Ung A, Pyne S, et al. Reversal of human multi-drug resistance leukaemic cells by stemofoline derivatives via inhibition of P-glycoprotein function. Basic Clin Pharmacol Toxicol. 2015;116:390-7 pubmed publisher

Tsukimoto M, Ohashi R, Torimoto N, Togo Y, Suzuki T, Maeda T, et al. Effects of the inhibition of intestinal P-glycoprotein on aliskiren pharmacokinetics in cynomolgus monkeys. Biopharm Drug Dispos. 2015;36:15-33 pubmed publisher

Bosgra S, van de Steeg E, Vlaming M, Verhoeckx K, Huisman M, Verwei M, et al. Predicting carrier-mediated hepatic disposition of rosuvastatin in man by scaling from individual transfected cell-lines in vitro using absolute transporter protein quantification and PBPK modeling. Eur J Pharm Sci. 2014;65:156-66 pubmed publisher

Takeshita J, Wang S, Shin D, Callis Duffin K, Krueger G, Kalb R, et al. Comparative effectiveness of less commonly used systemic monotherapies and common combination therapies for moderate to severe psoriasis in the clinical setting. J Am Acad Dermatol. 2014;71:1167-75 pubmed publisher

Kuo Y, Chen C, Goto S, Huang Y, Tsai C, Yang M. Proteomic analysis in serum of rat hind-limb allograft tolerance induced by immunosuppressive therapy with adipose-derived stem cells. Plast Reconstr Surg. 2014;134:1213-23 pubmed publisher

Xue L, Zhang W, Ding X, Zhang J, Bao J, Miao L. Population pharmacokinetics and individualized dosage prediction of cyclosporine in allogeneic hematopoietic stem cell transplant patients. Am J Med Sci. 2014;348:448-54 pubmed publisher

Giuliani A, Colognesi D, Ricco T, Roncato C, Capece M, Amoroso F, et al. Trophic activity of human P2X7 receptor isoforms A and B in osteosarcoma. PLoS ONE. 2014;9:e107224 pubmed publisher

Cho Y, Kee S, Kim T, Jin H, Kim M, Jung H, et al. Mucosal-associated invariant T cell deficiency in systemic lupus erythematosus. J Immunol. 2014;193:3891-901 pubmed publisher

Safa G, Luce K, Darrieux L, Tisseau L, Ortonne N. Erythrodermic CD8+ pseudolymphoma during infliximab treatment in a patient with psoriasis: use of cyclosporine as a rescue therapy. J Am Acad Dermatol. 2014;71:e149-50 pubmed publisher

Gao Z, Ma Y, Zhao D, Zhang X, Zhou H, Liu H, et al. Neochromine S5 improves contact hypersensitivity through a selective effect on activated T lymphocytes. Biochem Pharmacol. 2014;92:358-68 pubmed publisher

Gratuze M, Noël A, Julien C, Cisbani G, Milot Rousseau P, Morin F, et al. Tau hyperphosphorylation and deregulation of calcineurin in mouse models of Huntington's disease. Hum Mol Genet. 2015;24:86-99 pubmed publisher

Hu G, Wang K, Groenendyk J, Barakat K, Mizianty M, Michalak M, et al. Human structural proteome-wide characterization of Cyclosporine A targets. Bioinformatics. 2014;30:3561-6 pubmed publisher

Kam Y, Das T, Tian H, Foroutan P, Ruiz E, Martinez G, et al. Sweat but no gain: inhibiting proliferation of multidrug resistant cancer cells with "ersatzdroges". Int J Cancer. 2015;136:E188-96 pubmed publisher

Reichwald K, Jørgensen T, Skov S. TL1A increases expression of CD25, LFA-1, CD134 and CD154, and induces IL-22 and GM-CSF production from effector CD4 T-cells. PLoS ONE. 2014;9:e105627 pubmed publisher

Ma S, Liu X, Xu Q, Zhang X. Transport of ginkgolides with different lipophilicities based on an hCMEC/D3 cell monolayer as a blood-brain barrier cell model. Life Sci. 2014;114:93-101 pubmed publisher

Pandey S, Mahato P, Bhattacharyya S. Metabotropic glutamate receptor 1 recycles to the cell surface in protein phosphatase 2A-dependent manner in non-neuronal and neuronal cell lines. J Neurochem. 2014;131:602-14 pubmed publisher

Pereira R, Martinez G, Engel I, Cruz Guilloty F, Barboza B, Tsagaratou A, et al. Jarid2 is induced by TCR signalling and controls iNKT cell maturation. Nat Commun. 2014;5:4540 pubmed publisher

Hoerning A, Wilde B, Wang J, Tebbe B, Jing L, Wang X, et al. Pharmacodynamic monitoring of mammalian target of rapamycin inhibition by phosphoflow cytometric determination of p70S6 kinase activity. Transplantation. 2015;99:210-9 pubmed publisher

Qin Y, Fan Y, Mu X, Zhang F, Shen B, Liu Y, et al. Long-term use of ciclosporin on kidney transplant recipients surviving more than 10 years. Pharmazie. 2014;69:558-60 pubmed

Meissner K, Blood J, Francis A, Yermolenka V, Kharasch E. Cyclosporine-inhibitable cerebral drug transport does not influence clinical methadone pharmacodynamics. Anesthesiology. 2014;121:1281-91 pubmed publisher

Pelin M, Sosa S, Pacor S, Tubaro A, Florio C. The marine toxin palytoxin induces necrotic death in HaCaT cells through a rapid mitochondrial damage. Toxicol Lett. 2014;229:440-50 pubmed publisher

Hyung S, Feng X, Che Y, Stroh J, Shapiro M. Detection of conformation types of cyclosporin retaining intramolecular hydrogen bonds by mass spectrometry. Anal Bioanal Chem. 2014;406:5785-94 pubmed publisher

Gundala S, Yang C, Mukkavilli R, Paranjpe R, Brahmbhatt M, Pannu V, et al. Hydroxychavicol, a betel leaf component, inhibits prostate cancer through ROS-driven DNA damage and apoptosis. Toxicol Appl Pharmacol. 2014;280:86-96 pubmed publisher

Angoulvant D, Mewton N, Desebbe O, Obadia J, Robin J, Farhat F, et al. Cyclosporine protects the heart during aortic valve surgery. Anesthesiology. 2014;121:232-8 pubmed publisher

Van den Hof W, Van Summeren A, Lommen A, Coonen M, Brauers K, van Herwijnen M, et al. Integrative cross-omics analysis in primary mouse hepatocytes unravels mechanisms of cyclosporin A-induced hepatotoxicity. Toxicology. 2014;324:18-26 pubmed publisher

Habeshian K, Levitt J. Ophthalmic cyclosporine for the treatment of psoriatic conjunctivitis. J Am Acad Dermatol. 2014;71:e43-4 pubmed publisher

Pyo M, Yoon S, Yu Y, Park S, Jin M. Cyanidin-3-glucoside suppresses Th2 cytokines and GATA-3 transcription factor in EL-4 T cells. Biosci Biotechnol Biochem. 2014;78:1037-43 pubmed publisher

Wannhoff A, Weiss K, Schemmer P, Stremmel W, Gotthardt D. Increased levels of rivaroxaban in patients after liver transplantation treated with cyclosporine A. Transplantation. 2014;98:e12-3 pubmed publisher

Rostaing L, Christiaans M, Kovarik J, Pascual J. The pharmacokinetics of everolimus in de novo kidney transplant patients receiving tacrolimus: an analysis from the randomized ASSET study. Ann Transplant. 2014;19:337-45 pubmed publisher

Kim T, Kim J, Kim Z, Huang R, Chae Y, Wang R. Khz-cp (crude polysaccharide extract obtained from the fusion of Ganoderma lucidum and Polyporus umbellatus mycelia) induces apoptosis by increasing intracellular calcium levels and activating P38 and NADPH oxidase-dependent generation of reactive ox. BMC Complement Altern Med. 2014;14:236 pubmed publisher

Zhou A, Ryeom S. Cyclosporin A promotes tumor angiogenesis in a calcineurin-independent manner by increasing mitochondrial reactive oxygen species. Mol Cancer Res. 2014;12:1663-76 pubmed publisher

Cuppoletti J, Chakrabarti J, Tewari K, Malinowska D. Differentiation between human ClC-2 and CFTR Cl- channels with pharmacological agents. Am J Physiol Cell Physiol. 2014;307:C479-92 pubmed publisher

Laws P, Kingston T, Walsh S, Shear N. Cytomegalovirus retinitis: a rare but preventable cause of blindness in dermatology patients. J Cutan Med Surg. 2014;18:287-90 pubmed

Urbanellis P, Shyu W, Khattar R, Wang J, Zakharova A, He W, et al. The regulatory T cell effector molecule fibrinogen-like protein 2 is necessary for the development of rapamycin-induced tolerance to fully MHC-mismatched murine cardiac allografts. Immunology. 2015;144:91-106 pubmed publisher

Gaida K, Salimi Moosavi H, Subramanian R, Almon V, Knize A, Zhang M, et al. Inhibition of CRAC with a human anti-ORAI1 monoclonal antibody inhibits T-cell-derived cytokine production but fails to inhibit a T-cell-dependent antibody response in the cynomolgus monkey. J Immunotoxicol. 2015;12:164-73 pubmed publisher

Oh C, Huh K, Ha J, Kim Y, Kim Y, Kim Y. Safety and efficacy of the early introduction of everolimus with reduced-exposure cyclosporine a in de novo kidney recipients. Transplantation. 2015;99:180-6 pubmed publisher

Monfared A, Azimi S, Kazemnezhad E, Khosravi M, Lebadi M, Mirzajani E, et al. Hyperhomocysteinemia and assessment of its associated factors in renal transplant recipients: a single-center study in northern Iran. Transplantation. 2014;98:66-71 pubmed publisher

Nishimura R, Mase S, Araki R, Fujiki T, Kuroda R, Maeba H, et al. Massive hyper-reactive hematopoietic nests in bilateral iliac bones in a patient with mild aplastic anemia. Pediatr Blood Cancer. 2014;61:1903-4 pubmed publisher

Eriksson S, Elgström E, Bäck T, Ohlsson T, Jensen H, Nilsson R, et al. Sequential radioimmunotherapy with 177Lu- and 211At-labeled monoclonal antibody BR96 in a syngeneic rat colon carcinoma model. Cancer Biother Radiopharm. 2014;29:238-46 pubmed publisher

Daher Abdi Z, Premaud A, Essig M, Alain S, Munteanu E, Garnier F, et al. Exposure to mycophenolic acid better predicts immunosuppressive efficacy than exposure to calcineurin inhibitors in renal transplant patients. Clin Pharmacol Ther. 2014;96:508-15 pubmed publisher

Glaeser H, Bujok K, Schmidt I, Fromm M, Mandery K. Organic anion transporting polypeptides and organic cation transporter 1 contribute to the cellular uptake of the flavonoid quercetin. Naunyn Schmiedebergs Arch Pharmacol. 2014;387:883-91 pubmed publisher

Pastò A, Bellio C, Pilotto G, Ciminale V, Silic Benussi M, Guzzo G, et al. Cancer stem cells from epithelial ovarian cancer patients privilege oxidative phosphorylation, and resist glucose deprivation. Oncotarget. 2014;5:4305-19 pubmed

Jia X, Zhang H, Cao X, Yin Y, Zhang B. Activation of TRPV1 mediates thymic stromal lymphopoietin release via the Ca2+/NFAT pathway in airway epithelial cells. FEBS Lett. 2014;588:3047-54 pubmed publisher

Ma J, Liu N, Yi B, Zhang X, Gao B, Zhang Y, et al. Transplanted hUCB-MSCs migrated to the damaged area by SDF-1/CXCR4 signaling to promote functional recovery after traumatic brain injury in rats. Neurol Res. 2015;37:50-6 pubmed publisher

Muehlschlegel J. Closing the pore on reperfusion injury: myocardial protection with cyclosporine. Anesthesiology. 2014;121:212-3 pubmed publisher

Abela C, Hartmann C, De Leo A, de Sica Chapman A, Shah H, Jawad M, et al. Toxic epidermal necrolysis (TEN): the Chelsea and Westminster Hospital wound management algorithm. J Plast Reconstr Aesthet Surg. 2014;67:1026-32 pubmed publisher

Jia Y, Lu J, Huang Y, Liu G, Gao P, Wan Y, et al. The involvement of NFAT transcriptional activity suppression in SIRT1-mediated inhibition of COX-2 expression induced by PMA/Ionomycin. PLoS ONE. 2014;9:e97999 pubmed publisher

. Evaluation of organic anion transporting polypeptide 1B1 and 1B3 humanized mice as a translational model to study the pharmacokinetics of statins. Drug Metab Dispos. 2014;42:1301-13 pubmed publisher

Granato A, Hayashi E, Baptista B, Bellio M, Nobrega A. IL-4 regulates Bim expression and promotes B cell maturation in synergy with BAFF conferring resistance to cell death at negative selection checkpoints. J Immunol. 2014;192:5761-75 pubmed publisher

Blankenburg R, Hackert K, Wurster S, Deenen R, Seidman J, Seidman C, et al. β-Myosin heavy chain variant Val606Met causes very mild hypertrophic cardiomyopathy in mice, but exacerbates HCM phenotypes in mice carrying other HCM mutations. Circ Res. 2014;115:227-37 pubmed publisher

He H, Huang H, Yu T. Detection of DNA damage in sonochemotherapy against cisplatin-resistant human ovarian cancer cells using the modified comet assay. Int J Radiat Biol. 2014;90:897-902 pubmed publisher

Zhang Y, Bao S, Kuang Z, Ma Y, Hu Y, Mao Y. Urotensin II promotes monocyte chemoattractant protein-1 expression in aortic adventitial fibroblasts of rat. Chin Med J (Engl). 2014;127:1907-12 pubmed

Sidbury R, Davis D, Cohen D, Cordoro K, Berger T, Bergman J, et al. Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents. J Am Acad Dermatol. 2014;71:327-49 pubmed publisher

Luo C, Gao Y, Tang J, Zhu X, Xue H, Lu F, et al. ATG-Fresenius S combined with cyclosporine a: an effective immunosuppressive therapy for children with aplastic anemia. J Pediatr Hematol Oncol. 2014;36:374-8 pubmed publisher

Andress E, Nicolaou M, Romero M, Naik S, Dixon P, Williamson C, et al. Molecular mechanistic explanation for the spectrum of cholestatic disease caused by the S320F variant of ABCB4. Hepatology. 2014;59:1921-31 pubmed publisher

Kim S, Date T, Yokokawa H, Kono T, Aizaki H, Maurel P, et al. Development of hepatitis C virus genotype 3a cell culture system. Hepatology. 2014;60:1838-50 pubmed publisher

Peyre L, Rouimi P, De Sousa G, Héliès Toussaint C, Carré B, Barcellini S, et al. Comparative study of bisphenol A and its analogue bisphenol S on human hepatic cells: a focus on their potential involvement in nonalcoholic fatty liver disease. Food Chem Toxicol. 2014;70:9-18 pubmed publisher

Treiber A, Aänismaa P, de Kanter R, Delahaye S, Treher M, Hess P, et al. Macitentan does not interfere with hepatic bile salt transport. J Pharmacol Exp Ther. 2014;350:130-43 pubmed publisher

Nakazato R, Takarada T, Watanabe T, Nguyen B, Ikeno S, Hinoi E, et al. Constitutive and functional expression of runt-related transcription factor-2 by microglial cells. Neurochem Int. 2014;74:24-35 pubmed publisher

Ram J, Agarwal A. Images in clinical medicine. Giant papillae in vernal keratoconjunctivitis. N Engl J Med. 2014;370:1636 pubmed publisher

Yoshida T, Mihara K, Arihiro K, Mino T, Asaoku H, Ichinohe T. Concurrent administration of darbepoetin alfa, cyclosporine A, and prednisolone is useful for T cell large granular lymphocyte leukemia associated with myelodysplastic syndrome complicated by Coombs-negative hemolytic anemia. Ann Hematol. 2014;93:1937-9 pubmed publisher

Day A, Abramson A, Patel M, Warren R, Menter M. The spectrum of oculocutaneous disease: Part II. Neoplastic and drug-related causes of oculocutaneous disease. J Am Acad Dermatol. 2014;70:821.e1-19 pubmed publisher

Goldstein J, Fletcher S, Roth E, Wu C, Chun A, Horsley V. Calcineurin/Nfatc1 signaling links skin stem cell quiescence to hormonal signaling during pregnancy and lactation. Genes Dev. 2014;28:983-94 pubmed publisher

Cordeiro R, Macedo R, Teixeira C, Marques F, Bandeira T, Moreira J, et al. The calcineurin inhibitor cyclosporin A exhibits synergism with antifungals against Candida parapsilosis species complex. J Med Microbiol. 2014;63:936-944 pubmed publisher

Tramsen L, Schmidt S, Roeger F, Schubert R, Salzmann Manrique E, Latge J, et al. Immunosuppressive compounds exhibit particular effects on functional properties of human anti-Aspergillus Th1 cells. Infect Immun. 2014;82:2649-56 pubmed publisher

Albring A, Wendt L, Benson S, Nissen S, Yavuz Z, Engler H, et al. Preserving learned immunosuppressive placebo response: perspectives for clinical application. Clin Pharmacol Ther. 2014;96:247-55 pubmed publisher

Cho A, Tang Y, Davila J, Deng S, Chen L, Miller E, et al. Calcineurin signaling regulates neural induction through antagonizing the BMP pathway. Neuron. 2014;82:109-124 pubmed publisher

Hosseini M, Shaki F, Ghazi Khansari M, Pourahmad J. Toxicity of copper on isolated liver mitochondria: impairment at complexes I, II, and IV leads to increased ROS production. Cell Biochem Biophys. 2014;70:367-81 pubmed publisher

Tørring C, Andreasen C, Gehr N, Bjerg L, Petersen T, Höllsberg P. Higher incidence of Epstein-Barr virus-induced lymphocyte transformation in multiple sclerosis. Acta Neurol Scand. 2014;130:90-6 pubmed publisher

Forsythe P, Paterson S. Ciclosporin 10 years on: indications and efficacy. Vet Rec. 2014;174 Suppl 2:13-21 pubmed publisher

Nuttall T, Reece D, Roberts E. Life-long diseases need life-long treatment: long-term safety of ciclosporin in canine atopic dermatitis. Vet Rec. 2014;174 Suppl 2:3-12 pubmed publisher

Derniame S, Lee F, Domogala A, Madrigal A, Saudemont A. Unique effects of mycophenolate mofetil on cord blood T cells: implications for GVHD prophylaxis. Transplantation. 2014;97:870-8 pubmed publisher

Lopes P, Fuhrmann A, Sereno J, Espinoza D, Pereira M, Eriksson J, et al. Short and long term in vivo effects of Cyclosporine A and Sirolimus on genes and proteins involved in lipid metabolism in Wistar rats. Metabolism. 2014;63:702-15 pubmed publisher

Toh M, Bonnefoy J, Accart N, Cochin S, Pohle S, Haegel H, et al. Bone- and cartilage-protective effects of a monoclonal antibody against colony-stimulating factor 1 receptor in experimental arthritis. Arthritis Rheumatol. 2014;66:2989-3000 pubmed publisher

Toledo F, Pérez L, Basiglio C, Ochoa J, Sanchez Pozzi E, Roma M. The Ca²⁺-calmodulin-Ca²⁺/calmodulin-dependent protein kinase II signaling pathway is involved in oxidative stress-induced mitochondrial permeability transition and apoptosis in isolated rat hepatocytes. Arch Toxicol. 2014;88:1695-709 pubmed publisher

Winterdahl M, Audrain H, Landau A, Smith D, Bonaventure P, Shoblock J, et al. PET brain imaging of neuropeptide Y2 receptors using N-11C-methyl-JNJ-31020028 in pigs. J Nucl Med. 2014;55:635-9 pubmed publisher

Kimura Y, Fujimura C, Ito Y, Takahashi T, Aiba S. Evaluation of the Multi-ImmunoTox Assay composed of 3 human cytokine reporter cells by examining immunological effects of drugs. Toxicol In Vitro. 2014;28:759-68 pubmed publisher

Diémé B, Halimi J, Emond P, Buchler M, Nadal Desbarat L, Blasco H, et al. Assessing the metabolic effects of calcineurin inhibitors in renal transplant recipients by urine metabolic profiling. Transplantation. 2014;98:195-201 pubmed publisher

Nasu R, Nannya Y, Shinohara A, Ichikawa M, Kurokawa M. Favorable outcomes of tacrolimus compared with cyclosporine A for GVHD prophylaxis in HSCT for standard-risk hematological diseases. Ann Hematol. 2014;93:1215-23 pubmed publisher

Kim H, Kim K, Kim B, Jung H, Cho M, Lee S. Reciprocal activation of CD4+ T cells and synovial fibroblasts by stromal cell-derived factor 1 promotes RANKL expression and osteoclastogenesis in rheumatoid arthritis. Arthritis Rheumatol. 2014;66:538-48 pubmed publisher

Kogawa K, Sato H, Asano T, Ohga S, Kudo K, Morimoto A, et al. Prognostic factors of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children: report of the Japan Histiocytosis Study Group. Pediatr Blood Cancer. 2014;61:1257-62 pubmed publisher

Roodnat J, Hilbrands L, Hene R, de Sévaux R, Smak Gregoor P, Kal van Gestel J, et al. 15-year follow-up of a multicenter, randomized, calcineurin inhibitor withdrawal study in kidney transplantation. Transplantation. 2014;98:47-53 pubmed publisher

Onnheim K, Christenson K, Gabl M, Burbiel J, Muller C, Oprea T, et al. A novel receptor cross-talk between the ATP receptor P2Y2 and formyl peptide receptors reactivates desensitized neutrophils to produce superoxide. Exp Cell Res. 2014;323:209-17 pubmed publisher

Hausenloy D, Kunst G, Boston Griffiths E, Kolvekar S, Chaubey S, John L, et al. The effect of cyclosporin-A on peri-operative myocardial injury in adult patients undergoing coronary artery bypass graft surgery: a randomised controlled clinical trial. Heart. 2014;100:544-9 pubmed publisher

El Sheikh A, Koenderink J, Wouterse A, Van den Broek P, Verweij V, Masereeuw R, et al. Renal glucuronidation and multidrug resistance protein 2-/ multidrug resistance protein 4-mediated efflux of mycophenolic acid: interaction with cyclosporine and tacrolimus. Transl Res. 2014;164:46-56 pubmed publisher

Akopova O, Nosar V, Man kovskaia I, Sagach V. [The effect of Ca(2+)-induced opening of cyclosporine-sensitive pore on the oxygen consumption and functional state of rat liver mitochondria]. Ukr Biokhim Zh (1999). 2013;85:37-49 pubmed

Aragona P. Topical cyclosporine: are all indications justified?. Br J Ophthalmol. 2014;98:1001-2 pubmed publisher

Yargui L, Chettouh H, Boukni H, Mokhtari N, Berhoune A. Metabolic status of 1088 patients after renal transplantation: assessment of twelve years monitoring in Algiers Mustapha Hospital. Saudi J Kidney Dis Transpl. 2014;25:177-84 pubmed

Komagata Y. [Serious organ damage and intractable clinical conditions in rheumatic and connective tissue disease--progress in pathophysiology and treatment. Topics: II. Clinical conditions special attention needed to be paid to; 4. Macrophage activating syndrome. Nihon Naika Gakkai Zasshi. 2013;102:2639-44 pubmed

Liu K, Huynh K, Grubbs J, Davis R. Autoimmunity in the pathogenesis and treatment of keratoconjunctivitis sicca. Curr Allergy Asthma Rep. 2014;14:403 pubmed publisher

Hitzler J, He W, Doyle J, Cairo M, Camitta B, Chan K, et al. Outcome of transplantation for acute lymphoblastic leukemia in children with Down syndrome. Pediatr Blood Cancer. 2014;61:1126-8 pubmed publisher

Guedj J, Yu J, Levi M, Li B, Kern S, Naoumov N, et al. Modeling viral kinetics and treatment outcome during alisporivir interferon-free treatment in hepatitis C virus genotype 2 and 3 patients. Hepatology. 2014;59:1706-14 pubmed publisher

Watashi K, Sluder A, Daito T, Matsunaga S, Ryo A, Nagamori S, et al. Cyclosporin A and its analogs inhibit hepatitis B virus entry into cultured hepatocytes through targeting a membrane transporter, sodium taurocholate cotransporting polypeptide (NTCP). Hepatology. 2014;59:1726-37 pubmed publisher

Chang Q, Jing H, Sun M, Xu P. Exploring the role of short-course cyclosporin a therapy in preventing homograft valve calcification after transplantation. Cell Immunol. 2014;287:36-45 pubmed publisher

Melancon K, Mulgaonkar S, Delcoro C, Wiland A, McCague K, Shihab F. Outcomes in ethnic minority renal transplant recipients receiving everolimus versus mycophenolate: comparative risk assessment results from a pooled analysis. Transplantation. 2013;96:1073-81 pubmed publisher

Sacchetti M, Mantelli F, Lambiase A, Mastropasqua A, Merlo D, Bonini S. Systematic review of randomised clinical trials on topical ciclosporin A for the treatment of dry eye disease. Br J Ophthalmol. 2014;98:1016-22 pubmed publisher

Yagasaki H, Shichino H, Ohara A, Kobayashi R, Yabe H, Ohga S, et al. Immunosuppressive therapy with horse anti-thymocyte globulin and cyclosporine as treatment for fulminant aplastic anemia in children. Ann Hematol. 2014;93:747-52 pubmed publisher

Azzi J, Sayegh M, Mallat S. Calcineurin inhibitors: 40 years later, can't live without . J Immunol. 2013;191:5785-91 pubmed publisher

Hollie N, Cash J, Matlib M, Wortman M, Basford J, Abplanalp W, et al. Micromolar changes in lysophosphatidylcholine concentration cause minor effects on mitochondrial permeability but major alterations in function. Biochim Biophys Acta. 2014;1841:888-95 pubmed publisher

Unal S, Sağ E, Kuskonmaz B, Kesici S, Bayrakci B, Ayvaz D, et al. Successful treatment of severe myasthenia gravis developed after allogeneic hematopoietic stem cell transplantation with plasma exchange and rituximab. Pediatr Blood Cancer. 2014;61:928-30 pubmed publisher

Williams D, Bennett C, BERTUCH A, Bessler M, Coates T, Corey S, et al. Diagnosis and treatment of pediatric acquired aplastic anemia (AAA): an initial survey of the North American Pediatric Aplastic Anemia Consortium (NAPAAC). Pediatr Blood Cancer. 2014;61:869-74 pubmed publisher

Hirohata S. [Recent aspects of Neuro-Behcet's disease]. Brain Nerve. 2013;65:1245-53 pubmed

Rasaiyaah J, Tan C, Fletcher A, Price A, Blondeau C, Hilditch L, et al. HIV-1 evades innate immune recognition through specific cofactor recruitment. Nature. 2013;503:402-405 pubmed publisher

Hugh J, Van Voorhees A, Nijhawan R, Bagel J, Lebwohl M, Blauvelt A, et al. From the Medical Board of the National Psoriasis Foundation: The risk of cardiovascular disease in individuals with psoriasis and the potential impact of current therapies. J Am Acad Dermatol. 2014;70:168-77 pubmed publisher

Golardi N, Sramek J, Myers J, Saffer H, George T, Czuchlewski D. Two cases of concomitant acquired aplastic anemia and systemic mastocytosis. Hum Pathol. 2014;45:417-20 pubmed publisher

Kholmukhamedov A, Logdon C, Hu J, McKinney R, Spinale F, Lemasters J, et al. Cyclosporin A in left ventricular remodeling after myocardial infarction. Am J Physiol Heart Circ Physiol. 2014;306:H53-9 pubmed publisher

Bondarenko A, Jean Quartier C, Parichatikanond W, Alam M, Waldeck Weiermair M, Malli R, et al. Mitochondrial Ca(2+) uniporter (MCU)-dependent and MCU-independent Ca(2+) channels coexist in the inner mitochondrial membrane. Pflugers Arch. 2014;466:1411-20 pubmed publisher

Yang C, Zhang T, Li Z, Xu L, Liu F, Ruan J, et al. P-glycoprotein is responsible for the poor intestinal absorption and low toxicity of oral aconitine: in vitro, in situ, in vivo and in silico studies. Toxicol Appl Pharmacol. 2013;273:561-8 pubmed publisher

Faralli J, Gagen D, Filla M, Crotti T, Peters D. Dexamethasone increases ?v?3 integrin expression and affinity through a calcineurin/NFAT pathway. Biochim Biophys Acta. 2013;1833:3306-3313 pubmed publisher

Renner B, Klawitter J, Goldberg R, McCullough J, Ferreira V, Cooper J, et al. Cyclosporine induces endothelial cell release of complement-activating microparticles. J Am Soc Nephrol. 2013;24:1849-62 pubmed publisher

Loo T, Clarke D. Drug rescue distinguishes between different structural models of human P-glycoprotein. Biochemistry. 2013;52:7167-9 pubmed publisher

Kapoor K, Bhatnagar J, Chufan E, Ambudkar S. Mutations in intracellular loops 1 and 3 lead to misfolding of human P-glycoprotein (ABCB1) that can be rescued by cyclosporine A, which reduces its association with chaperone Hsp70. J Biol Chem. 2013;288:32622-36 pubmed publisher

Horneff G, Rhouma A, Weber C, Lohse P. Macrophage activation syndrome as the initial manifestation of tumour necrosis factor receptor 1-associated periodic syndrome (TRAPS). Clin Exp Rheumatol. 2013;31:99-102 pubmed

Amparo F, Jin Y, Hamrah P, Schaumberg D, Dana R. What is the value of incorporating tear osmolarity measurement in assessing patient response to therapy in dry eye disease?. Am J Ophthalmol. 2014;157:69-77.e2 pubmed publisher

Cetrulo C, Torabi R, Scalea J, Shimizu A, Leto Barone A, Gillon B, et al. Vascularized composite allograft transplant survival in miniature swine: is MHC tolerance sufficient for acceptance of epidermis?. Transplantation. 2013;96:966-74 pubmed publisher

Bayers S, Arkin L, Bohaty B, Paller A. Neurotoxicity in the setting of pediatric atopic dermatitis treated with modified cyclosporine and itraconazole. J Am Acad Dermatol. 2013;69:e177-8 pubmed publisher

Sahay M, Sahay R, Narayan G. New-onset diabetes after transplantation--role of oral glucose tolerance test for diagnosis and study of risk factors. Saudi J Kidney Dis Transpl. 2013;24:897-902 pubmed

Eisenberg S. The case of the toxic transplant tremors. ONS Connect. 2013;28:41 pubmed

Schulze Lohoff E, Kloft K, Vogelbusch G. [70-year-old kidney transplant patient with anorexia and weight loss. Kaposi sarcoma]. Dtsch Med Wochenschr. 2013;138:1885-6 pubmed publisher

Giannitti C, Fineschi I, Frediani B, Fioravanti A, Galeazzi M. Efficacy and safety of tocilizumab combined with cyclosporine A in a patient with rheumatoid arthritis and concomitant chronic hepatitis C virus infection. Clin Exp Rheumatol. 2013;31:816 pubmed

Akopova O, Nosar V, Buryĭ V, Kolchinskaia L, Man kovskaia I, Sagach V. [The effect of ATP-dependent K(+)-channel opener on the functional state and the opening of cyclosporine-sensitive pore in rat liver mitochondria]. Ukr Biokhim Zh (1999). 2013;85:38-51 pubmed

Ando K, Nakashita T, Kaneko N, Takahashi K, Motojima S. Long-term efficacy and safety of maintenance therapy with azathioprine or cyclosporine for interstitial lung disease with diffuse cutaneous scleroderma. Clin Exp Rheumatol. 2013;31:191-2 pubmed

Fukushima K, Miki T, Nakamoto K, Nishimura A, Koyama H, Ichikawa H, et al. Effect of intestinal atrophy and hepatic impairment induced by parenteral nutrition on drug absorption and disposition in rats. JPEN J Parenter Enteral Nutr. 2015;39:218-27 pubmed publisher

Peinemann F, Bartel C, Grouven U. First-line allogeneic hematopoietic stem cell transplantation of HLA-matched sibling donors compared with first-line ciclosporin and/or antithymocyte or antilymphocyte globulin for acquired severe aplastic anemia. Cochrane Database Syst Rev. 2013;:CD006407 pubmed publisher

Pivovarov A, Murzina G, Tret iakova M, Makhnovskii D. [Role of serine/threonine and tyrosine protein phosphatases in command Helix lucorum neurons at the cellular correlate of habituation]. Zh Vyssh Nerv Deiat Im I P Pavlova. 2013;63:256-68 pubmed

Valk Swinkels C, Alidjan F, Rommers M, Bakker R, Swen J, van t Veer N. [Low cyclosporin levels induced by the brief use of rifampicin; immunosuppression may fail for several weeks]. Ned Tijdschr Geneeskd. 2013;157:A5667 pubmed

Bushley K, Raja R, Jaiswal P, Cumbie J, Nonogaki M, Boyd A, et al. The genome of tolypocladium inflatum: evolution, organization, and expression of the cyclosporin biosynthetic gene cluster. PLoS Genet. 2013;9:e1003496 pubmed publisher

Andreev D, Abramova N, Blinova M, Pinaev G. [Efficacy of dermoplasty and the dermal equivalent in treatment of vast leg ulcers of mixed genesis]. Vestn Khir Im I I Grek. 2013;172:104-7 pubmed

Mathieson P. Immunosuppression for membranous nephropathy - Authors' reply. Lancet. 2013;381:2163 pubmed publisher

Chen Z, Du X. Immunosuppression for membranous nephropathy. Lancet. 2013;381:2162-3 pubmed publisher

Cirillo M. Immunosuppression for membranous nephropathy. Lancet. 2013;381:2161 pubmed publisher

McNeil C. Preventing graft-versus-host disease: transplanters glimpse hope beyond immunosuppressants. J Natl Cancer Inst. 2013;105:922-3 pubmed publisher

Gao J, Sana R, Calder V, Calonge M, Lee W, Wheeler L, et al. Mitochondrial permeability transition pore in inflammatory apoptosis of human conjunctival epithelial cells and T cells: effect of cyclosporin A. Invest Ophthalmol Vis Sci. 2013;54:4717-33 pubmed publisher

Lim D, Park Y, Kim S, Jeong S, Kim S. Diagnostic value of tolerance-related gene expression measured in the recipient alloantigen-reactive T cell fraction. Clin Immunol. 2013;148:219-26 pubmed publisher

Piao S, Kang S, Lim S, Chung B, Doh K, Heo S, et al. Influence of N-acetylcysteine on Klotho expression and its signaling pathway in experimental model of chronic cyclosporine nephropathy in mice. Transplantation. 2013;96:146-53 pubmed publisher

Lommer M. Efficacy of cyclosporine for chronic, refractory stomatitis in cats: A randomized, placebo-controlled, double-blinded clinical study. J Vet Dent. 2013;30:8-17 pubmed

Mourer J, de Koning E, van Zwet E, Mallat M, Rabelink T, de Fijter J. Impact of late calcineurin inhibitor withdrawal on ambulatory blood pressure and carotid intima media thickness in renal transplant recipients. Transplantation. 2013;96:49-57 pubmed publisher

Tirosh Levy S. Clinical snapshot: Corneal edema in a Tennessee walking horse. Compend Contin Educ Vet. 2013;35:E7 pubmed

Marcoux J, Wang S, Politis A, Reading E, Ma J, Biggin P, et al. Mass spectrometry reveals synergistic effects of nucleotides, lipids, and drugs binding to a multidrug resistance efflux pump. Proc Natl Acad Sci U S A. 2013;110:9704-9 pubmed publisher

Remuzzi G, Ruggenenti P. ACP Journal Club. Prednisolone plus chlorambucil preserved renal function in membranous nephropathy. Ann Intern Med. 2013;158:JC9 pubmed publisher

Flechner S, Gurkan A, Hartmann A, Legendre C, Russ G, Campistol J, et al. A randomized, open-label study of sirolimus versus cyclosporine in primary de novo renal allograft recipients. Transplantation. 2013;95:1233-41 pubmed publisher

Shimanskaia T, Strutinskaia N, Vavilova G, Goshovskaia I, Semenikhina E, Sagach V. [Cyclosporin A-sensitive mitochondrial pore as a target of cardioprotective action of hydrogen sulfide donor]. Ross Fiziol Zh Im I M Sechenova. 2013;99:261-72 pubmed

Atlani M, Sharma R, Gupta A. Basiliximab induction in renal transplantation: long-term outcome. Saudi J Kidney Dis Transpl. 2013;24:473-9 pubmed

Unadkat J, Bourbeau D, Afrooz P, Solari M, Washington K, Pulikkottil B, et al. Functional outcomes following multiple acute rejections in experimental vascularized composite allotransplantation. Plast Reconstr Surg. 2013;131:720e-30e pubmed publisher

Vichyanond P, Kosrirukvongs P. Use of cyclosporine A and tacrolimus in treatment of vernal keratoconjunctivitis. Curr Allergy Asthma Rep. 2013;13:308-14 pubmed publisher

First M, Dhadda S, Croy R, Holman J, Fitzsimmons W. New-onset diabetes after transplantation (NODAT): an evaluation of definitions in clinical trials. Transplantation. 2013;96:58-64 pubmed publisher

Climov M, Măciuceanu Zarnescu M, Stefanescu A, Zamfirescu D, Lascar I. Learning curve in hemifacial transplantation in rats. Chirurgia (Bucur). 2013;108:234-40 pubmed

Zhou Y, Sheng X, Xu J, Bi S, Lu W, Cui Y. Population pharmacokinetic study of cyclosporine in the hematopoietic stem cell transplant recipients. Int J Clin Pharmacol Ther. 2013;51:568-75 pubmed publisher

Arns W, Sommerer C, Glander P, Ariatabar T, Porstner M, May C, et al. A randomized trial of intensified vs. standard dosing for enteric-coated mycophenolate sodium in de novo kidney transplant recipients: results at 1 year. Clin Nephrol. 2013;79:421-31 pubmed publisher

Hodge G, Hodge S, Ahern J, Holmes Liew C, Reynolds P, Holmes M. Up-regulation of alternate co-stimulatory molecules on proinflammatory CD28null T cells in bronchiolitis obliterans syndrome. Clin Exp Immunol. 2013;173:150-60 pubmed publisher

Uchino H, Hatakeyama K, Morota S, Tanoue T, Nishiyama T, Usui D, et al. Cyclophilin-D inhibition in neuroprotection: dawn of a new era of mitochondrial medicine. Acta Neurochir Suppl. 2013;118:311-5 pubmed publisher

Kamata S, Miyagawa S, Fukushima S, Nakatani S, Kawamoto A, Saito A, et al. Improvement of cardiac stem cell sheet therapy for chronic ischemic injury by adding endothelial progenitor cell transplantation: analysis of layer-specific regional cardiac function. Cell Transplant. 2014;23:1305-19 pubmed publisher

Paziana K, Del Monaco M, Cardonick E, Moritz M, Keller M, Smith B, et al. Ciclosporin use during pregnancy. Drug Saf. 2013;36:279-94 pubmed publisher

Cheng M. Hartmann Stahelin (1925-2011) and the contested history of cyclosporin A. Clin Transplant. 2013;27:326-9 pubmed publisher

Yilmaz M, Eskazan A, Unsal A, Taninmis H, Kara E, Cetiner M, et al. Cyclosporin A therapy on idiopathic thrombotic thrombocytopenic purpura in the relapse setting: two case reports and a review of the literature. Transfusion. 2013;53:1586-93 pubmed publisher

Yavuz B, Bozdag Pehlivan S, Unlu N. An overview on dry eye treatment: approaches for cyclosporin a delivery. ScientificWorldJournal. 2012;2012:194848 pubmed publisher

Kovalik M, Thoday K, Van Den Broek A. The use of ciclosporin A in veterinary dermatology. Vet J. 2012;193:317-25 pubmed publisher

Yan R, Zhang Z, Fang X, Hu Y, Zhu H. Synthesis, molecular docking and biological evaluation of 1,3,4-oxadiazole derivatives as potential immunosuppressive agents. Bioorg Med Chem. 2012;20:1373-9 pubmed publisher

Liu Z, Shi Q, Ding D, Kelly R, Fang H, Tong W. Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps). PLoS Comput Biol. 2011;7:e1002310 pubmed publisher

Roh C, Kim S, Jo S. Label free inhibitor screening of hepatitis C virus (HCV) NS5B viral protein using RNA oligonucleotide. Sensors (Basel). 2011;11:6685-96 pubmed publisher

Liu M, Wang S, Zhou Y, Xiang T, Dong H, Yang K, et al. An iminosugar N-pentafluorobenzyl-1-deoxynojirimycin as a novel potential immunosuppressant for the treatment of Th2-related diseases. Bioorg Med Chem Lett. 2012;22:564-70 pubmed publisher

Lee M, Song S, Jung S, Hur S, Asahara T, Kim H, et al. Effect of ionizing radiation induced damage of endothelial progenitor cells in vascular regeneration. Arterioscler Thromb Vasc Biol. 2012;32:343-52 pubmed publisher

Schumann M, Jahreis G, Kahlert V, Lücke C, Fischer G. Oligopeptide cyclophilin inhibitors: a reassessment. Eur J Med Chem. 2011;46:5556-61 pubmed publisher

Hausenloy D, Boston Griffiths E, Yellon D. Cyclosporin A and cardioprotection: from investigative tool to therapeutic agent. Br J Pharmacol. 2012;165:1235-45 pubmed publisher

Mansueto P, Pisciotta G, Tomasello G, Cabibi D, Seidita A, D Alcamo A, et al. Malignant tumor-like gastric lesion due to Candida albicans in a diabetic patient treated with cyclosporin: a case report and review of the literature. Clin Exp Med. 2012;12:201-5 pubmed publisher

Lee S, Lee W, Kim Y, Kim Y, Ko H. Synthesis and biological evaluation of α,β-unsaturated lactones as potent immunosuppressive agents. Bioorg Med Chem Lett. 2011;21:5726-9 pubmed publisher

Chen M, Vijay V, Shi Q, Liu Z, Fang H, Tong W. FDA-approved drug labeling for the study of drug-induced liver injury. Drug Discov Today. 2011;16:697-703 pubmed publisher

Combes S, Barbier P, Douillard S, McLeer Florin A, Bourgarel Rey V, Pierson J, et al. Synthesis and biological evaluation of 4-arylcoumarin analogues of combretastatins. Part 2. J Med Chem. 2011;54:3153-62 pubmed publisher

Gozalbes R, Jacewicz M, Annand R, Tsaioun K, Pineda Lucena A. QSAR-based permeability model for drug-like compounds. Bioorg Med Chem. 2011;19:2615-24 pubmed publisher

Strader C, Pearce C, Oberlies N. Fingolimod (FTY720): a recently approved multiple sclerosis drug based on a fungal secondary metabolite. J Nat Prod. 2011;74:900-7 pubmed publisher

Survase S, Kagliwal L, Annapure U, Singhal R. Cyclosporin A--a review on fermentative production, downstream processing and pharmacological applications. Biotechnol Adv. 2011;29:418-35 pubmed publisher

Di Tommaso C, Behar Cohen F, Gurny R, Moller M. Colloidal systems for the delivery of cyclosporin A to the anterior segment of the eye. Ann Pharm Fr. 2011;69:116-23 pubmed publisher

Kim H, Kim K, Jung H, Yoon K, Oh H, Cho M, et al. Macrophage migration inhibitory factor enhances osteoclastogenesis through upregulation of RANKL expression from fibroblast-like synoviocytes in patients with rheumatoid arthritis. Arthritis Res Ther. 2011;13:R43 pubmed publisher

Pang X, Zhang M, Zhou L, Xie F, Lu H, He W, et al. Discovery of a potent peptidic cyclophilin A inhibitor Trp-Gly-Pro. Eur J Med Chem. 2011;46:1701-5 pubmed publisher

O Connell S, Slattery C, Ryan M, McMorrow T. Identification of novel indicators of cyclosporine A nephrotoxicity in a CD-1 mouse model. Toxicol Appl Pharmacol. 2011;252:201-10 pubmed publisher

Broccatelli F, Carosati E, Neri A, Frosini M, Goracci L, Oprea T, et al. A novel approach for predicting P-glycoprotein (ABCB1) inhibition using molecular interaction fields. J Med Chem. 2011;54:1740-51 pubmed publisher

Lulic D, Burns J, Bae E, Van Loveren H, Borlongan C. A review of laboratory and clinical data supporting the safety and efficacy of cyclosporin A in traumatic brain injury. Neurosurgery. 2011;68:1172-85; discussion 1185-6 pubmed publisher

Stefanidis C, Querfeld U. The podocyte as a target: cyclosporin A in the management of the nephrotic syndrome caused by WT1 mutations. Eur J Pediatr. 2011;170:1377-83 pubmed publisher

Pyott S, Schwarze U, Christiansen H, Pepin M, Leistritz D, Dineen R, et al. Mutations in PPIB (cyclophilin B) delay type I procollagen chain association and result in perinatal lethal to moderate osteogenesis imperfecta phenotypes. Hum Mol Genet. 2011;20:1595-609 pubmed publisher

Jang M, Lin Y, De Jonghe S, Gao L, Vanderhoydonck B, Froeyen M, et al. Discovery of 7-N-piperazinylthiazolo[5,4-d]pyrimidine analogues as a novel class of immunosuppressive agents with in vivo biological activity. J Med Chem. 2011;54:655-68 pubmed publisher

Lv P, Cai T, Qian Y, Sun J, Zhu H. Synthesis, biological evaluation of chrysin derivatives as potential immunosuppressive agents. Eur J Med Chem. 2011;46:393-8 pubmed publisher

Pinsonneault R, Mayer N, Mayer F, Tegegn N, Bainton R. Novel models for studying the blood-brain and blood-eye barriers in Drosophila. Methods Mol Biol. 2011;686:357-69 pubmed publisher

Scribner A, Houck D, Huang Z, Mosier S, Peel M, Scorneaux B. Synthesis and biological evaluation of [D-lysine]8cyclosporin A analogs as potential anti-HCV agents. Bioorg Med Chem Lett. 2010;20:6542-6 pubmed publisher

Ekins S, Williams A, Xu J. A predictive ligand-based Bayesian model for human drug-induced liver injury. Drug Metab Dispos. 2010;38:2302-8 pubmed publisher

Utine C, Stern M, Akpek E. Clinical review: topical ophthalmic use of cyclosporin A. Ocul Immunol Inflamm. 2010;18:352-61 pubmed publisher

Sagiv Barfi I, Weiss E, Levitzki A. Design, synthesis, and evaluation of quinazoline T cell proliferation inhibitors. Bioorg Med Chem. 2010;18:6404-13 pubmed publisher

Kockx M, Jessup W, Kritharides L. Cyclosporin A and atherosclerosis--cellular pathways in atherogenesis. Pharmacol Ther. 2010;128:106-18 pubmed publisher

Zhang P, Wong I, Yan C, Zhang X, Jiang T, Chow L, et al. Design and syntheses of permethyl ningalin B analogues: potent multidrug resistance (MDR) reversal agents of cancer cells. J Med Chem. 2010;53:5108-20 pubmed publisher

Greene N, Fisk L, Naven R, Note R, Patel M, Pelletier D. Developing structure-activity relationships for the prediction of hepatotoxicity. Chem Res Toxicol. 2010;23:1215-22 pubmed publisher

Ouakaa Kchaou A, Gargouri D, Elloumi H, Kharrat J, Ghorbel A. Ciclosporin for severe refractory colitis. Tunis Med. 2010;88:390-3 pubmed

Gommermann N, Buehlmayer P, von Matt A, Breitenstein W, Masuya K, Pirard B, et al. New pyrazolo[1,5a]pyrimidines as orally active inhibitors of Lck. Bioorg Med Chem Lett. 2010;20:3628-31 pubmed publisher

Avdeef A, Tam K. How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?. J Med Chem. 2010;53:3566-84 pubmed publisher

Giacomini K, Huang S, Tweedie D, Benet L, Brouwer K, Chu X, et al. Membrane transporters in drug development. Nat Rev Drug Discov. 2010;9:215-36 pubmed publisher

Puyang X, Poulin D, Mathy J, Anderson L, Ma S, Fang Z, et al. Mechanism of resistance of hepatitis C virus replicons to structurally distinct cyclophilin inhibitors. Antimicrob Agents Chemother. 2010;54:1981-7 pubmed publisher

Varma M, Obach R, Rotter C, Miller H, Chang G, Steyn S, et al. Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. J Med Chem. 2010;53:1098-108 pubmed publisher

Jang M, De Jonghe S, Van Belle K, Louat T, Waer M, Herdewijn P. Synthesis, immunosuppressive activity and structure-activity relationship study of a new series of 4-N-piperazinyl-thieno[2,3-d]pyrimidine analogues. Bioorg Med Chem Lett. 2010;20:844-7 pubmed publisher

Ovadia O, Linde Y, Haskell Luevano C, Dirain M, Sheynis T, Jelinek R, et al. The effect of backbone cyclization on PK/PD properties of bioactive peptide-peptoid hybrids: the melanocortin agonist paradigm. Bioorg Med Chem. 2010;18:580-9 pubmed publisher

Uehara T, Ono A, Maruyama T, Kato I, Yamada H, Ohno Y, et al. The Japanese toxicogenomics project: application of toxicogenomics. Mol Nutr Food Res. 2010;54:218-27 pubmed publisher

Fourches D, Barnes J, Day N, Bradley P, Reed J, Tropsha A. Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chem Res Toxicol. 2010;23:171-83 pubmed publisher

Hopkins S, Scorneaux B, Huang Z, Murray M, Wring S, Smitley C, et al. SCY-635, a novel nonimmunosuppressive analog of cyclosporine that exhibits potent inhibition of hepatitis C virus RNA replication in vitro. Antimicrob Agents Chemother. 2010;54:660-72 pubmed publisher

Wagner J, von Matt P, Sedrani R, Albert R, Cooke N, Ehrhardt C, et al. Discovery of 3-(1H-indol-3-yl)-4-[2-(4-methylpiperazin-1-yl)quinazolin-4-yl]pyrrole-2,5-dione (AEB071), a potent and selective inhibitor of protein kinase C isotypes. J Med Chem. 2009;52:6193-6 pubmed publisher

Zhang Y, Erdmann F, Fischer G. Augmented photoswitching modulates immune signaling. Nat Chem Biol. 2009;5:724-6 pubmed publisher

Yuan J, Johnson R, Huang R, Wichterman J, Jiang H, Hayton K, et al. Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum. Nat Chem Biol. 2009;5:765-71 pubmed publisher

Desino K, Ansar S, Georg G, Himes R, Michaelis M, Powell D, et al. (3R,5S,7as)-(3,5-Bis(4-fluorophenyl)tetrahydro-1H-oxazolo[3,4-c]oxazol-7a-yl)methanol, a novel neuroprotective agent. J Med Chem. 2009;52:7537-43 pubmed publisher

Ni S, Yuan Y, Huang J, Mao X, Lv M, Zhu J, et al. Discovering potent small molecule inhibitors of cyclophilin A using de novo drug design approach. J Med Chem. 2009;52:5295-8 pubmed publisher

Cheng Y, Chang M, Lo Y, Ho C, Kuo Y, Chien C, et al. Oxygenated lignans from the fruits of Schisandra arisanensis. J Nat Prod. 2009;72:1663-8 pubmed publisher

Liu G, Xu J, He C, Chen G, Xu Q, Xu H, et al. Synthesis and evaluation of a novel series of quinoline derivatives with immunosuppressive activity. Bioorg Med Chem. 2009;17:5433-41 pubmed publisher

Donnenberg V, Meyer E, Donnenberg A. Measurement of multiple drug resistance transporter activity in putative cancer stem/progenitor cells. Methods Mol Biol. 2009;568:261-79 pubmed publisher

Chang D, Yoon E, Lee G, Kim S, Kim W, Kim Y, et al. Design, synthesis and identification of novel colchicine-derived immunosuppressant. Bioorg Med Chem Lett. 2009;19:4416-20 pubmed publisher

Shou Q, Tan Q, Shen Z. Hirtellanines A and B, a pair of isomeric isoflavonoid derivatives from Campylotropis hirtella and their immunosuppressive activities. Bioorg Med Chem Lett. 2009;19:3389-91 pubmed publisher

Qing M, Yang F, Zhang B, Zou G, Robida J, Yuan Z, et al. Cyclosporine inhibits flavivirus replication through blocking the interaction between host cyclophilins and viral NS5 protein. Antimicrob Agents Chemother. 2009;53:3226-35 pubmed publisher

Varma M, Feng B, Obach R, Troutman M, Chupka J, Miller H, et al. Physicochemical determinants of human renal clearance. J Med Chem. 2009;52:4844-52 pubmed publisher

Bruno O, Brullo C, Bondavalli F, Schenone S, Spisani S, Falzarano M, et al. 1-Methyl and 1-(2-hydroxyalkyl)-5-(3-alkyl/cycloalkyl/phenyl/naphthylureido)-1H-pyrazole-4-carboxylic acid ethyl esters as potent human neutrophil chemotaxis inhibitors. Bioorg Med Chem. 2009;17:3379-87 pubmed publisher

Li J, Tan Z, Tang S, Hewlett I, Pang R, He M, et al. Discovery of dual inhibitors targeting both HIV-1 capsid and human cyclophilin A to inhibit the assembly and uncoating of the viral capsid. Bioorg Med Chem. 2009;17:3177-88 pubmed publisher

Klinkhammer W, Müller H, Globisch C, Pajeva I, Wiese M. Synthesis and biological evaluation of a small molecule library of 3rd generation multidrug resistance modulators. Bioorg Med Chem. 2009;17:2524-35 pubmed publisher

O Brien R, Taylor M, Hartley J, Nuhsbaum T, Dugan S, Lahmers K, et al. Protective role of gammadelta T cells in spontaneous ocular inflammation. Invest Ophthalmol Vis Sci. 2009;50:3266-74 pubmed publisher

Coelmont L, Kaptein S, Paeshuyse J, Vliegen I, Dumont J, Vuagniaux G, et al. Debio 025, a cyclophilin binding molecule, is highly efficient in clearing hepatitis C virus (HCV) replicon-containing cells when used alone or in combination with specifically targeted antiviral therapy for HCV (STAT-C) inhibitors. Antimicrob Agents Chemother. 2009;53:967-76 pubmed publisher

Santana L, González Díaz H, Quezada E, Uriarte E, Yáñez M, Viña D, et al. Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors. J Med Chem. 2008;51:6740-51 pubmed publisher

Ahlin G, Karlsson J, Pedersen J, Gustavsson L, Larsson R, Matsson P, et al. Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1. J Med Chem. 2008;51:5932-42 pubmed publisher

Leyers S, Häcker H, Wiendlocha J, Gutschow M, Wiese M. A 4-aminobenzoic acid derivative as novel lead for selective inhibitors of multidrug resistance-associated proteins. Bioorg Med Chem Lett. 2008;18:4761-3 pubmed publisher

Pick A, Müller H, Wiese M. Structure-activity relationships of new inhibitors of breast cancer resistance protein (ABCG2). Bioorg Med Chem. 2008;16:8224-36 pubmed publisher

Paeshuyse J, Vliegen I, Coelmont L, Leyssen P, Tabarrini O, Herdewijn P, et al. Comparative in vitro anti-hepatitis C virus activities of a selected series of polymerase, protease, and helicase inhibitors. Antimicrob Agents Chemother. 2008;52:3433-7 pubmed publisher

He Q, Jiang H, Zhang F, Chen H, Tang G. Simultaneous identification of multiple receptors of natural product using an optimized cDNA phage display cloning. Bioorg Med Chem Lett. 2008;18:3995-8 pubmed publisher

Goumenos D. What have we learned from the use of ciclosporin A in the treatment of nephrotic patients with idiopathic membranous nephropathy?. Expert Opin Pharmacother. 2008;9:1695-704 pubmed

Colabufo N, Berardi F, Contino M, Inglese C, Niso M, Perrone R. Effect of some P-glycoprotein modulators on Rhodamine-123 absorption in guinea-pig ileum. Bioorg Med Chem Lett. 2008;18:3741-4 pubmed publisher

Pedersen J, Matsson P, Bergström C, Norinder U, Hoogstraate J, Artursson P. Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2). J Med Chem. 2008;51:3275-87 pubmed publisher

Van de Vijver P, Ostrowski T, Sproat B, Goebels J, Rutgeerts O, Van Aerschot A, et al. Aminoacyl-tRNA synthetase inhibitors as potent and synergistic immunosuppressants. J Med Chem. 2008;51:3020-9 pubmed publisher

Obach R, Lombardo F, Waters N. Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug Metab Dispos. 2008;36:1385-405 pubmed publisher

Wagner E, Al Kadasi K, Zimecki M, Sawka Dobrowolska W. Synthesis and pharmacological screening of derivatives of isoxazolo[4,5-d]pyrimidine. Eur J Med Chem. 2008;43:2498-504 pubmed publisher

DiMauro E, Newcomb J, Nunes J, Bemis J, Boucher C, Chai L, et al. Structure-guided design of aminopyrimidine amides as potent, selective inhibitors of lymphocyte specific kinase: synthesis, structure-activity relationships, and inhibition of in vivo T cell activation. J Med Chem. 2008;51:1681-94 pubmed publisher

Colabufo N, Berardi F, Cantore M, Perrone M, Contino M, Inglese C, et al. 4-Biphenyl and 2-naphthyl substituted 6,7-dimethoxytetrahydroisoquinoline derivatives as potent P-gp modulators. Bioorg Med Chem. 2008;16:3732-43 pubmed publisher

Colabufo N, Berardi F, Perrone R, Rapposelli S, Digiacomo M, Vanni M, et al. Synthesis and biological evaluation of (hetero)arylmethyloxy- and arylmethylamine-phenyl derivatives as potent P-glycoprotein modulating agents. J Med Chem. 2008;51:1415-22 pubmed publisher

Ptak R, Gallay P, Jochmans D, Halestrap A, Ruegg U, Pallansch L, et al. Inhibition of human immunodeficiency virus type 1 replication in human cells by Debio-025, a novel cyclophilin binding agent. Antimicrob Agents Chemother. 2008;52:1302-17 pubmed publisher

Kashani S, Mearza A. Uses and safety profile of ciclosporin in ophthalmology. Expert Opin Drug Saf. 2008;7:79-89 pubmed

Müller H, Pajeva I, Globisch C, Wiese M. Functional assay and structure-activity relationships of new third-generation P-glycoprotein inhibitors. Bioorg Med Chem. 2008;16:2448-62 pubmed

Zhuang D, Smedema M, Lemonte A, Book B, Pescovitz M, Wheat L. Effect of calcineurin inhibitors on posaconazole blood levels as measured by the MVista microbiological assay. Antimicrob Agents Chemother. 2008;52:730-1 pubmed

Zhang L, Yu J, Pan H, Hu P, Hao Y, Cai W, et al. Small molecule regulators of autophagy identified by an image-based high-throughput screen. Proc Natl Acad Sci U S A. 2007;104:19023-8 pubmed

Hess S, Ovadia O, Shalev D, Senderovich H, Qadri B, Yehezkel T, et al. Effect of structural and conformation modifications, including backbone cyclization, of hydrophilic hexapeptides on their intestinal permeability and enzymatic stability. J Med Chem. 2007;50:6201-11 pubmed

Madan V, Griffiths C. Systemic ciclosporin and tacrolimus in dermatology. Dermatol Ther. 2007;20:239-50 pubmed

Liu X, Tee H, Go M. Functionalized chalcones as selective inhibitors of P-glycoprotein and breast cancer resistance protein. Bioorg Med Chem. 2008;16:171-80 pubmed

Colabufo N, Berardi F, Cantore M, Perrone M, Contino M, Inglese C, et al. Small P-gp modulating molecules: SAR studies on tetrahydroisoquinoline derivatives. Bioorg Med Chem. 2008;16:362-73 pubmed

Galeazzi M, Bellisai F, Giannitti C, Manganelli S, Morozzi G, Sebastiani G. Safety of cyclosporin A in HCV-infected patients: experience with cyclosporin A in patients affected by rheumatological disorders and concomitant HCV infection. Ann N Y Acad Sci. 2007;1110:544-9 pubmed

Müller H, Klinkhammer W, Globisch C, Kassack M, Pajeva I, Wiese M. New functional assay of P-glycoprotein activity using Hoechst 33342. Bioorg Med Chem. 2007;15:7470-9 pubmed

Loo T, Bartlett M, Clarke D. Suppressor mutations in the transmembrane segments of P-glycoprotein promote maturation of processing mutants and disrupt a subset of drug-binding sites. J Biol Chem. 2007;282:32043-52 pubmed

Liu H, Wang Y, Li S. Advanced delivery of ciclosporin A: present state and perspective. Expert Opin Drug Deliv. 2007;4:349-58 pubmed

Tong L, Phan T, Robinson K, Babusis D, Strab R, Bhoopathy S, et al. Effects of human immunodeficiency virus protease inhibitors on the intestinal absorption of tenofovir disoproxil fumarate in vitro. Antimicrob Agents Chemother. 2007;51:3498-504 pubmed

Onyewu C, Eads E, Schell W, Perfect J, Ullmann Y, Kaufman G, et al. Targeting the calcineurin pathway enhances ergosterol biosynthesis inhibitors against Trichophyton mentagrophytes in vitro and in a human skin infection model. Antimicrob Agents Chemother. 2007;51:3743-6 pubmed

Gong Y, Christensen E, Gluud C. Cyclosporin A for primary biliary cirrhosis. Cochrane Database Syst Rev. 2007;:CD005526 pubmed

Rottenberg S, Nygren A, Pajic M, van Leeuwen F, van der Heijden I, van de Wetering K, et al. Selective induction of chemotherapy resistance of mammary tumors in a conditional mouse model for hereditary breast cancer. Proc Natl Acad Sci U S A. 2007;104:12117-22 pubmed

Bruno O, Brullo C, Bondavalli F, Ranise A, Schenone S, Falzarano M, et al. 2-Phenyl-2,3-dihydro-1H-imidazo[1,2-b]pyrazole derivatives: new potent inhibitors of fMLP-induced neutrophil chemotaxis. Bioorg Med Chem Lett. 2007;17:3696-701 pubmed

Park S, Oh H, Kang M, Cho H, Prasad J, Won J, et al. The structure-activity relationship of the series of non-peptide small antagonists for p56lck SH2 domain. Bioorg Med Chem. 2007;15:3938-50 pubmed

Diamandis P, Wildenhain J, Clarke I, Sacher A, Graham J, Bellows D, et al. Chemical genetics reveals a complex functional ground state of neural stem cells. Nat Chem Biol. 2007;3:268-73 pubmed

Tejedor A, Torres A, Castilla M, Lazaro J, de Lucas C, Caramelo C. Cilastatin protection against cyclosporin A-induced nephrotoxicity: clinical evidence. Curr Med Res Opin. 2007;23:505-13 pubmed

Jankowska M, Butto B, Debska Slizien A, Rutkowski B. Beneficial effect of treatment with cyclosporin A in a case of refractory antisynthetase syndrome. Rheumatol Int. 2007;27:775-80 pubmed

Betton G, Kenne K, Somers R, Marr A. Protein biomarkers of nephrotoxicity; a review and findings with cyclosporin A, a signal transduction kinase inhibitor and N-phenylanthranilic acid. Cancer Biomark. 2005;1:59-67 pubmed

Zhang Y, Zhong X, Zheng Z, Hu X, Zuo J, Hu L. Discovery and synthesis of new immunosuppressive alkaloids from the stem of Fissistigma oldhamii (Hemsl.) Merr. Bioorg Med Chem. 2007;15:988-96 pubmed

Ibarra A, Diaz Ruiz A. Protective effect of cyclosporin-A in spinal cord injury: an overview. Curr Med Chem. 2006;13:2703-10 pubmed

Italia J, Bhardwaj V, Kumar M. Disease, destination, dose and delivery aspects of ciclosporin: the state of the art. Drug Discov Today. 2006;11:846-54 pubmed

Baraldo M, Furlanut M. Chronopharmacokinetics of ciclosporin and tacrolimus. Clin Pharmacokinet. 2006;45:775-88 pubmed

Burckart G. Ciclosporin aerosol in lung transplantation. Expert Opin Investig Drugs. 2006;15:981-6 pubmed

Pereira T, Vieira A, Fernandes J, Sousa Basto A. Cyclosporin A treatment in severe childhood psoriasis. J Eur Acad Dermatol Venereol. 2006;20:651-6 pubmed

Griffiths C, Katsambas A, Dijkmans B, Finlay A, Ho V, Johnston A, et al. Update on the use of ciclosporin in immune-mediated dermatoses. Br J Dermatol. 2006;155 Suppl 2:1-16 pubmed

Chapman J, Nankivell B. Nephrotoxicity of ciclosporin A: short-term gain, long-term pain?. Nephrol Dial Transplant. 2006;21:2060-3 pubmed

Guichou J, Viaud J, Mettling C, Subra G, Lin Y, Chavanieu A. Structure-based design, synthesis, and biological evaluation of novel inhibitors of human cyclophilin A. J Med Chem. 2006;49:900-10 pubmed

Tohyama K, Ishikawa T. [Immunosuppressive therapy of refractory anemia--clinical trials of cyclosporin A therapy in Japan]. Rinsho Ketsueki. 2005;46:324-9 pubmed

Berth Jones J. The use of ciclosporin in psoriasis. J Dermatolog Treat. 2005;16:258-77 pubmed

V lckova Laskoska M. Cyclosporin A-induced gingival hyperplasia in psoriasis: review of the literature and case reports. Acta Dermatovenerol Croat. 2005;13:108-13 pubmed

Durai D, Hawthorne A. Review article: how and when to use ciclosporin in ulcerative colitis. Aliment Pharmacol Ther. 2005;22:907-16 pubmed

Tatlipinar S, Akpek E. Topical ciclosporin in the treatment of ocular surface disorders. Br J Ophthalmol. 2005;89:1363-7 pubmed

Webster A, Woodroffe R, Taylor R, Chapman J, Craig J. Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data. BMJ. 2005;331:810 pubmed

Yang Z, Zhou W, Sui Y, Wang J, Wu J, Zhou Y, et al. Synthesis and immunosuppressive activity of new artemisinin derivatives. 1. [12(beta or alpha)-Dihydroartemisininoxy]phen(ox)yl aliphatic acids and esters. J Med Chem. 2005;48:4608-17 pubmed

Wang Y, Li Y, Li Y, Yang S, Yang L. Modeling K(m) values using electrotopological state: substrates for cytochrome P450 3A4-mediated metabolism. Bioorg Med Chem Lett. 2005;15:4076-84 pubmed

Laube S, Stephens M, Smith A, Whittaker S, Tan B. Lymphomatoid papulosis in a patient with atopic eczema on long-term ciclosporin therapy. Br J Dermatol. 2005;152:1346-8 pubmed

Ye X, Sun F, Liu M, Li Q, Wang Y, Zhang G, et al. Synthetic iminosugar derivatives as new potential immunosuppressive agents. J Med Chem. 2005;48:3688-91 pubmed

Kiang T, Ensom M, Chang T. UDP-glucuronosyltransferases and clinical drug-drug interactions. Pharmacol Ther. 2005;106:97-132 pubmed

Chang M, Yang Y, Kuo Y, Kuo Y, Chang C, Chen C, et al. Furocoumarin glycosides from the leaves of Ficus ruficaulis Merr. var. antaoensis. J Nat Prod. 2005;68:11-3 pubmed

Watashi K, Hijikata M, Hosaka M, Yamaji M, Shimotohno K. Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes. Hepatology. 2003;38:1282-8 pubmed

Nelson P, Akselband Y, Kawamura A, Su M, Tung R, Rich D, et al. Immunosuppressive activity of [MeBm2t]1-, D-diaminobutyryl-8-, and D-diaminopropyl-8-cyclosporin analogues correlates with inhibition of calcineurin phosphatase activity. J Immunol. 1993;150:2139-47 pubmed

Clipstone N, Fiorentino D, Crabtree G. Molecular analysis of the interaction of calcineurin with drug-immunophilin complexes. J Biol Chem. 1994;269:26431-7 pubmed

Nichols R, Suplick G, Brown J. Calcineurin-mediated protein dephosphorylation in brain nerve terminals regulates the release of glutamate. J Biol Chem. 1994;269:23817-23 pubmed

Kronke M, Leonard W, Depper J, Arya S, Wong Staal F, Gallo R, et al. Cyclosporin A inhibits T-cell growth factor gene expression at the level of mRNA transcription. Proc Natl Acad Sci U S A. 1984;81:5214-8 pubmed

Emmel E, Verweij C, Durand D, Higgins K, Lacy E, Crabtree G. Cyclosporin A specifically inhibits function of nuclear proteins involved in T cell activation. Science. 1989;246:1617-20 pubmed

Manger B, Hardy K, Weiss A, Stobo J. Differential effect of cyclosporin A on activation signaling in human T cell lines. J Clin Invest. 1986;77:1501-6 pubmed